In addition, prominent characteristics of cancer cells associated with an enhanced epithelial–mesenchymal transition (EMT) phenotype and cancer aggressiveness advanced in response to SEMA6D overexpression in cancer breast cells (increased migration and invasion ability) and in normal breast cells (increased migration). This evidence concerns the gene SEMA6D and cancer.